M2I Life Sciences

About:

A world-class industrial partner for custom synthesis and formulation of niche products in Healthcare.

Website: http://www.m2i-lifesciences.com

Twitter/X: contactm2i

Top Investors: Eurazeo, Creadev, Cibus Fund, Bootstrap Europe, Idinvest Partners

Description:

M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant.

Total Funding Amount:

72M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lacq, Aquitaine, France

Founded Date:

2013-01-01

Founders:

Philippe Guerret

Number of Employees:

101-250

Last Funding Date:

2020-11-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai